Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.
Kaftanovskaya EM, Ng HH, Soula M, Rivas B, Myhr C, Ho BA, Cervantes BA, Shupe TD, Devarasetty M, Hu X, Xu X, Patnaik S, Wilson KJ, Barnaeva E, Ferrer M, Southall NT, Marugan JJ, Bishop CE, Agoulnik IU, Agoulnik AI. Kaftanovskaya EM, et al. Among authors: agoulnik iu. FASEB J. 2019 Nov;33(11):12435-12446. doi: 10.1096/fj.201901046R. Epub 2019 Aug 16. FASEB J. 2019. PMID: 31419161 Free PMC article.
The role of relaxin in endometrial cancer.
Kamat AA, Feng S, Agoulnik IU, Kheradmand F, Bogatcheva NV, Coffey D, Sood AK, Agoulnik AI. Kamat AA, et al. Among authors: agoulnik ai, agoulnik iu. Cancer Biol Ther. 2006 Jan;5(1):71-7. doi: 10.4161/cbt.5.1.2289. Epub 2006 Jan 31. Cancer Biol Ther. 2006. PMID: 16322684
Relaxin promotes prostate cancer progression.
Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Clin Cancer Res. 2007 Mar 15;13(6):1695-702. doi: 10.1158/1078-0432.CCR-06-2492. Clin Cancer Res. 2007. PMID: 17363522
Relaxin signaling in uterine fibroids.
Li Z, Burzawa JK, Troung A, Feng S, Agoulnik IU, Tong X, Anderson ML, Kovanci E, Rajkovic A, Agoulnik AI. Li Z, et al. Among authors: agoulnik ai, agoulnik iu. Ann N Y Acad Sci. 2009 Apr;1160:374-8. doi: 10.1111/j.1749-6632.2008.03803.x. Ann N Y Acad Sci. 2009. PMID: 19416222 Free PMC article.
Relaxin/RXFP1 signaling in prostate cancer progression.
Feng S, Agoulnik IU, Li Z, Han HD, Lopez-Berestein G, Sood A, Ittmann MM, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Ann N Y Acad Sci. 2009 Apr;1160:379-80. doi: 10.1111/j.1749-6632.2008.03793.x. Ann N Y Acad Sci. 2009. PMID: 19416223 Free PMC article.
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
Feng S, Agoulnik IU, Truong A, Li Z, Creighton CJ, Kaftanovskaya EM, Pereira R, Han HD, Lopez-Berestein G, Klonisch T, Ittmann MM, Sood AK, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Endocr Relat Cancer. 2010 Oct 29;17(4):1021-33. doi: 10.1677/ERC-10-0073. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20861284
54 results